Olink Holding Ab Publ Asset Turnover Ratio (OLK), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Olink Holding Ab publ   (NASDAQ: OLK)
 

Olink Holding Ab Publ Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Olink Holding Ab Publ asset turnover ratio, the ability of Olink Holding Ab Publ 's assets to generate revenue in the fourth quarter 2023, increased sequentially to 0.25 in the fourth quarter (Dec 31 2023), yet the ratio remained below the average, as OLK's position remain challenging.

Within sector 13 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from 2560 to 2950.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OLK Asset Turnover Ratio (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Asset Change 16.92 % 26.45 % 26.45 % 26.45 % -8.51 %
Y / Y Revenue Change 21.18 % - - - 47.25 %
Asset Turnover Ratio (TTM) 0.25 - - - 0.25
OLK's Total Ranking # 2950 # 2560 # 2894 # 0 # 3947
Seq. Asset Change 48.91 % 0 % 0 % -21.48 % 61.03 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 14
Healthcare Sector # 414
Overall Market # 2950

Asset Turnover Ratio Statistics
High Average Low
0.29 0.25 0.18
(Dec 31 2022)   (Dec 31 2021)




OLK Company Profile • Back to OLK Efficiency Comparisons • Compare OLK Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Vireo Growth Inc.  0.52 $ 88.133  Millions$ 169.879  Millions
Burning Rock Biotech Limited  0.52 $ 75.696  Millions$ 146.482  Millions
Johnson and Johnson  0.52 $ 93,022.000  Millions$ 180,318.500  Millions
Karyopharm Therapeutics Inc   0.52 $ 146.033  Millions$ 283.507  Millions
Baxter International Inc   0.51 $ 14,813.000  Millions$ 28,777.000  Millions
Capricor Therapeutics inc   0.51 $ 25.178  Millions$ 48.940  Millions
Icu Medical Inc  0.51 $ 2,259.126  Millions$ 4,422.245  Millions
Fonar Corporation  0.51 $ 102.422  Millions$ 200.934  Millions
Esperion Therapeutics Inc   0.51 $ 116.334  Millions$ 228.386  Millions
Alnylam Pharmaceuticals Inc   0.51 $ 1,828.292  Millions$ 3,615.822  Millions
Ge Healthcare Technologies Inc   0.51 $ 16,387.000  Millions$ 32,446.000  Millions
Castle Biosciences Inc   0.50 $ 219.788  Millions$ 435.413  Millions
Brainsway Ltd   0.50 $ 31.785  Millions$ 62.972  Millions
Xeris Biopharma Holdings Inc   0.50 $ 163.914  Millions$ 325.131  Millions
U S Physical Therapy Inc  0.50 $ 487.150  Millions$ 968.783  Millions
Harrow Inc   0.50 $ 130.126  Millions$ 259.929  Millions
Intuitive Surgical Inc   0.50 $ 7,123.500  Millions$ 14,277.675  Millions
Agape Atp Corporation  0.50 $ 1.431  Millions$ 2.871  Millions
Shl Telemedicine Ltd  0.50 $ 57.075  Millions$ 114.743  Millions
Cutera Inc   0.50 $ 211.494  Millions$ 427.132  Millions
Amphastar Pharmaceuticals Inc   0.49 $ 644.395  Millions$ 1,302.367  Millions
Axsome Therapeutics Inc   0.49 $ 270.600  Millions$ 547.478  Millions
Coherus Oncology inc   0.49 $ 257.244  Millions$ 521.351  Millions
Livanova Plc  0.49 $ 1,153.250  Millions$ 2,348.856  Millions
Ardelyx inc   0.49 $ 124.456  Millions$ 253.795  Millions
Lifestance Health Group Inc   0.49 $ 1,055.665  Millions$ 2,153.629  Millions
Steris Plc  0.49 $ 5,407.384  Millions$ 11,080.503  Millions
Pacific Health Care Organization Inc  0.49 $ 5.630  Millions$ 11.594  Millions
Bristol myers Squibb Company  0.48 $ 45,006.000  Millions$ 93,548.000  Millions
Prophase Labs Inc   0.48 $ 44.239  Millions$ 92.517  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.